D. J. Chan, L. Mcnally, M. Batterham, and D. E. Smith, Relationship between HIV-RNA load in blood and semen in antiretroviral-naïve and experienced men and effect of asymptomatic sexually transmissible infections, Curr HIV Res, vol.6, pp.138-142, 2008.

D. J. Chan, J. E. Ray, L. Mcnally, M. Batterham, and D. E. Smith, Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs, Curr HIV Res, vol.6, pp.477-484, 2008.

P. L. Vernazza, L. Troiani, M. J. Flepp, R. W. Cone, J. Schock et al., Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study, AIDS, vol.14, pp.117-121, 2000.

P. M. Sheth, C. Kovacs, K. S. Kemal, R. B. Jones, J. M. Raboud et al., Persistent HIV RNA shedding in semen despite effective antiretroviral therapy, AIDS, vol.23, pp.2050-2054, 2009.

J. A. Politch, K. H. Mayer, S. L. Welles, W. X. O'brien, C. Xu et al., Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men, AIDS, vol.26, pp.1535-1543, 2012.

G. Lorello, C. La-porte, R. Pilon, G. Zhang, T. Karnauchow et al., Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma, HIV Med, vol.10, pp.548-554, 2009.

S. Taylor and S. Davies, Antiretroviral drug concentrations in the male and female genital tract: implications for the sexual transmission of HIV, Curr Opin HIV AIDS, vol.5, pp.335-343, 2010.

C. R. Trezza and A. Kashuba, Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention, Clin Pharmacokinet, vol.53, pp.611-624, 2014.

L. J. Else, S. Taylor, D. J. Back, and S. H. Khoo, Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract, Antivir Ther (Lond), vol.16, pp.1149-1167, 2011.

J. B. Dumond, Y. S. Reddy, L. Troiani, J. F. Rodriguez, A. S. Bridges et al., Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men, J Acquir Immune Defic Syndr, vol.48, pp.156-162, 2008.

J. M. Baeten, D. Donnell, P. Ndase, N. R. Mugo, J. D. Campbell et al., Antiretroviral prophylaxis for HIV prevention in heterosexual men and women, N Engl J Med, vol.367, pp.399-410, 2012.

R. M. Grant, J. R. Lama, P. L. Anderson, V. Mcmahan, A. Y. Liu et al., Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, iPrEx Study Team, vol.363, pp.2587-2599, 2010.

J. Ghosn, M. Chaix, G. Peytavin, R. E. Bresson, J. Goujard et al., Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV1-infected men, AIDS, vol.18, pp.1958-1961, 2004.

S. H. Lowe, E. Van-leeuwen, J. Droste, F. Van-der-veen, P. Reiss et al., Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen, Ther Drug Monit, vol.29, pp.566-570, 2007.

M. Vourvahis, H. L. Tappouni, K. B. Patterson, Y. Chen, N. L. Rezk et al., The pharmacokinetics and viral activity of tenofovir in the male genital tract, J Acquir Immune Defic Syndr, vol.47, pp.329-333, 2008.

K. B. Patterson, H. A. Prince, E. Kraft, A. J. Jenkins, N. J. Shaheen et al., Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission, Sci Transl Med, vol.3, 2011.

K. R. Robillard, T. Hoque, and R. Bendayan, Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier, J Pharmacol Exp Ther, vol.340, pp.96-108, 2012.

V. Jullien, J. Tréluyer, R. E. Jaffray, P. Krivine, A. Moachon et al., Population pharmacokinetics of tenofovir in human immunodeficiency virusinfected patients taking highly active antiretroviral therapy, Antimicrob Agents Chemother, vol.49, pp.3361-3366, 2005.

B. P. Kearney, A. Mathias, A. Mittan, J. Sayre, R. Ebrahimi et al., Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir, J Acquir Immune Defic Syndr, vol.43, pp.278-283, 2006.

J. J. Kiser, M. L. Carten, C. L. Aquilante, P. L. Anderson, P. Wolfe et al., The effect of lopinavir/ ritonavir on the renal clearance of tenofovir in HIV-infected patients, Clin Pharmacol Ther, vol.83, pp.265-272, 2008.

B. M. Best, S. L. Letendre, P. Koopmans, S. S. Rossi, D. B. Clifford et al., Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir, J Acquir Immune Defic Syndr, vol.59, pp.376-381, 2012.

J. B. Dumond, R. F. Yeh, K. B. Patterson, A. H. Corbett, B. H. Jung et al., Antiretroviral drug exposure in the female genital tract: implications for oral pre-and post-exposure prophylaxis, AIDS, vol.21, pp.1899-1907, 2007.

J. B. Dumond, M. R. Nicol, R. N. Kendrick, S. M. Garonzik, K. B. Patterson et al., Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women, Clin Pharmacokinet, vol.51, pp.809-822, 2012.

A. S. Ray, T. Cihlar, K. L. Robinson, L. Tong, J. E. Vela et al., Mechanism of active renal tubular efflux of tenofovir, Antimicrob Agents Chemother, vol.50, pp.3297-3304, 2006.

S. P. Pushpakom, N. J. Liptrott, S. Rodríguez-nóvoa, P. Labarga, V. Soriano et al., Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction, J Infect Dis, vol.204, pp.145-153, 2011.

S. Rodriguez-novoa, P. Labarga, and V. Soriano, Pharmacogenetics of tenofovir treatment, Pharmacogenomics, vol.10, pp.1675-1685, 2009.

E. Valade, J. Tréluyer, S. M. Illamola, N. Bouazza, F. Foissac et al., Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the Evarist-ANRS EP 49 study, Antimicrob Agents Chemother, vol.59, pp.6800-6806, 2015.

J. Ghosn, M. Leruez-ville, J. Blanche, A. Delobelle, C. Beaudoux et al., HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens, Clin Infect Dis, vol.58, pp.1763-1770, 2014.

S. Illamola, E. Valade, D. Hirt, E. Dulioust, J. Wolf et al., Each matrix is singular. Development and validation of a LC-MS/MS method for the quantification of tenofovir and emtricitabine in plasma and seminal plasma, J Chromatogr B, pp.234-241, 2016.

V. Michaud, T. Bar-magen, J. Turgeon, D. Flockhart, Z. Desta et al., The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition, Pharmacol Rev, vol.64, pp.803-833, 2012.

Z. Xu and J. A. Taylor, SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies, Nucleic Acids Res, vol.37, pp.600-605, 2009.

K. Rungtivasuwan, A. Avihingsanon, N. Thammajaruk, S. Mitruk, D. M. Burger et al., Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients, Antimicrob Agents Chemother, vol.59, pp.3240-3245, 2015.

J. J. Kiser, C. L. Aquilante, P. L. Anderson, T. M. King, M. L. Carten et al., Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients, J Acquir Immune Defic Syndr, vol.47, pp.298-303, 2008.

A. Calcagno, J. Cusato, L. Marinaro, L. Trentini, C. Alcantarini et al., Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines, Pharmacogenomics J, vol.16, pp.514-518, 2016.

E. Kuhn and M. Lavielle, Maximum likelihood estimation in nonlinear mixed effects models, Comput Stat Data Anal, vol.49, pp.1020-1038, 2005.

M. Bergstrand, A. C. Hooker, J. E. Wallin, and M. O. Karlsson, Predictioncorrected visual predictive checks for diagnosing nonlinear mixed-effects models, AAPS J, vol.13, pp.143-151, 2011.

M. Li, J. Yeung, S. S. Cherny, and P. C. Sham, Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets, Hum Genet, vol.131, pp.747-756, 2012.

R. Ihaka and R. Gentleman, R: a language for data analysis and graphics, J Comput Graph Stat, vol.5, pp.299-314, 1996.

D. Bates, M. Maechler, B. Bolker, and S. Walker, lme4: fitting linear mixed-effects models using Eigen and S4, J Stat Software, vol.67, pp.1-48, 2015.